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Abstract: Regenerative medicine is an emerging field of the
healthcare industry that has the potential to treat a myriad of health
conditions. Induced pluripotent stem cells, human embryonic stem
cells, and tissue engineering are a few of the treatment methods
that may be delivered by healthcare professionals in personalized
medicine. Food and Drug Administration (FDA) approval is
necessary within the United States before any of these treatment
options are available. Specific cellular therapies are currently
undergoing clinical trials and it may be years before approval is
acquired. The National Institute of Health is proactively working
to ensure that healthcare policies, costs, regulations, protocols,
and provisions are implemented to ensure that risks are minimized
in the case of FDA approval. Regenerative rehabilitation will
improve traditional healthcare delivery, increasing health,
function, and quality of life for patients with a variety of conditions.
Keywords: regenerative medicine, regenerative rehabilitation, stem cells,
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cellular therapy, regenerative cell therapy, stem cell rehabilitation, cell
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Regenerative Medicine
Throughout the years, medicine has begun to advance at an
astounding rate. Consequently, these rapid advancements have led to
emerging and polarizing therapies within the field of regenerative medicine.
Notably within this sector, stem cell therapies are surfacing that allow
medical professionals to target and treat the human body in ways that were
once considered impossible. Hanley, Rastegarlari, and Nathwani (2010)
discuss the ability of induced pluripotent stem cells and human embryonic
stem cells to differentiate into every type of cell. Stem cell capabilities
reveal that anatomical structures within the body could be regenerated and
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rehabilitated. Spinal cord injuries, congenital defects, cognitive deficits,
cardiac disease, anatomical abnormalities and amputations are just some
of the types of conditions that regenerative medicine could treat and heal.
Induced pluripotent stem cells will likely focus more on disease treatment
while embryonic stem cells will concentrate on debilitating injuries and
degenerative disorders (Hanley, Rastegarlari, Nathwani, 2010). Ethical
concerns primarily center on the acquisition of human embryonic stem
cells rather than induced pluripotent stem cells. King and Perrin (2014)
outline that stem cell opposition regards a human embryo as having moral
standing because it may form into a human, therefore it would be unethical
to harm an embryo to harvest stem cells. Despite current opposition, this
groundbreaking therapy should be fully supported through its infancy
because the therapeutic use of stem cells possesses the potential to
revolutionize medicine and rehabilitation.
Regenerative Therapy
Cellular therapies that focus on the use of stem cells are emerging
which will allow medical professionals to target and heal injuries and other
physical conditions. According to the Mayo Clinic (n.d.), rejuvenation,
replacement, and regeneration are the three interrelated approaches used
to create and establish effective regenerative medicine for the future. This
is a dynamic method towards an emerging field of medicine and therapy
that has the potential to address every physical issue or disability that an
individual may encounter. For example, stem cells are able to differentiate
into any somatic cell such as skin cells, brain cells, and lung cells (Mayo
Clinic, n.d.). According to the National Institute of Biomedical Imaging
and Bioengineering (2017), an alternative to stem cells for regenerative
medicine is tissue engineering in which biomaterials are used to develop
functional tissues through a combination of scaffolding with cells.
Regenerative medicine is an exciting and emerging field of healthcare that
has the potential to heal every condition imaginable.
National and Community Healthcare Issue
Healthcare commonly draws criticism within the United States,
however few topics within the industry create the polarizing and heated
discussions as regenerative therapies. Bioethics represent the foundation in
which regenerative medicine opposition resides, and fear on both a national
and local level fuels the debates about accessing the benefits of stem cell
therapy. Stock (2003) acknowledged a variety of fears in healthcare and
provides an interesting perspective that describes issues and concerns
surrounding the field of regenerative medicine. Abuse of regenerative
technologies, philosophical implications based on regenerative therapy, and
recognizing that we do not control our future even with regenerative medicine
are three of the fears that were analyzed by Stock (2003). Nationally, the
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United States would have to regulate and control regenerative technologies
to prevent abuse; it is safe to assume that America is not currently capable
or prepared to control such a task. Medicine and therapies require the
implementation of protocols, guidelines, and procedures to minimize risk,
however since regenerative therapy is an ever-changing and emerging field
that has not yet attained FDA approval it would be fruitless to create such
precise provisions. Locally, fear extends to individuals on a philosophical
level, it is difficult to predict whether an individual would be able to accept a
regenerative body part (Stock, 2003). Also, it could in turn make individuals
question their identity as humans because of the regenerative change they
will undergo (Stock, 2003). On a long-term global scale, evolution will
be strongly impacted by the decision made to utilize such a therapy and
it is unclear what will be achieved because it is currently unknown how
future technologies will impact self-directed evolution through the use of
regenerative medicine (Stock, 2003). Deliberation of pros and cons will be
a continuous and enduring effort of individuals and this nation, however
the immense benefits to human life and the ever changing nature of humans
will certainly push regenerative medicine into the practical world.
Delivery of Healthcare
Contemporary healthcare delivery methods will be implemented
for regenerative therapy and it will strongly differ from that of traditional
healthcare delivery. The National Institute of Health examined business
models and settings in which regenerative medicine could operate.
Rao (2015) acknowledges that hospital based services and the idea of
homegrown tissues are two potential therapeutic settings for regenerative
medicine, and a new stem cell therapy would significantly impact
healthcare delivery. Rao (2015) acknowledges the inevitable difficulty
that traditional pharmacological institutes would experience when trying
to deliver and manufacture regenerative therapies. Regenerative medicine
is personalized medicine, therefore large manufacturing companies would
struggle to transition from indirect consumer delivery because they tend
to the condition and not the individual. The National Institute of Health
is proactively working to prevent such a delivery issue and is analyzing
potential solutions for the future of regenerative healthcare delivery (Rao,
2015). It is important to realize that today’s pharmacological approach
to healthcare delivery is based on automatic machinery that produces its
supply of products in bulk for a range of conditions. Alternative settings
like hospital based services, institutional based services, and home settings
will work best because individuals are directly tending to their therapeutic
needs with professional guidance (Rao, 2015). Distributing revolutionary
regenerative therapies is a difficult proposition since it has never been done,
ultimately, new and safe delivery methods will emerge to meet its demand.
Distribution of cell therapy is not the only concern, as healthcare
delivery also encompasses the application of the therapy for the patient.
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Silva and Lederman (2004) acknowledge the methods of cellular therapy
delivery include systemic delivery, local delivery, surgical delivery,
and catheter delivery. Methods of delivery would be dependent upon
the patient’s condition, preference, and location. Each delivery method
possesses their own unique benefits and risks. Systemic delivery would
be used for cardiovascular application via placement of stem cells within
intravenous infusion (Silva & Lederman, 2004). Local delivery would take
place through a needle into the injection site, this would allow for a larger
and more accurate treatment (Silva & Lederman, 2004). Surgical stem cell
implantation is a highly targeted method of delivery that would take place
in high demanding circumstances so that the best results may be obtained
(Silva & Lederman, 2004). Catheter delivery is an alternative option to the
previous methods that percutaneously sends stem cells into a region of the
body (Silva & Lederman, 2004). Cell therapy has yet to establish itself as
a reliable and sanctioned method of treatment, it is important to realize that
these methods of deliveries will evolve and adapt to the demands of patients
as regenerative medicine evolves in the future.
Impacted Populations
Various populations of individuals with physical disabilities,
diseases and injuries would be overwhelmingly impacted by the arrival
of regenerative therapies. Cellular therapy is an expanding and inclusive
market that will target specific diseases across a spectrum of illnesses and
conditions. Syed and Evans (2013) state that in 2011 the stem cell market
was worth $2.7 billion and projected that in 2016 it would have been worth
$8.8 billion. While these markets are not based on the United States, they are
based off of regenerative markets and provide an idea of the impact it would
have within the United States’ healthcare sector. For example, orthopedic
injuries regularly involve musculoskeletal structures; these conditions would
be cured if regenerative medicine were accessible. Greco (2015) outlines
and focuses on types of arthritis and how this population would utilize
stem cell therapy to enhance their quality of life. Osteoarthritis, traumatic
arthritis, and rheumatoid arthritis were highlighted within the article and
each of these possess structural damage, yet the author discusses instances
in which experimental use of stem cells improves a participant’s health
(Greco, 2015). Current surgical treatments include microfracture surgery,
arthroplasty, osteotomy, and osteochondral autograft transfer system
surgery. During microfracture surgery, a doctor drills microscopic holes in
the bone to stimulate inflammation for cartilaginous healing in a localized
area. Arthroplasty requires a surgeon to reshape bones to reconstruct a
joint. An osteotomy dictates that a surgeon removes part of a bone, and
then stabilize the remaining bone with pins to reduce weight bearing on the
injured area (Greco, 2015). Osteochondral autograft transfer system surgery
involves moving healthy cartilage to a damaged site to reduce pain (Greco,
2015). Stem cell therapy would be a desirable alternative to the current
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traumatic surgical treatments. In theory, any disease could be reversible or
curable by stem cells, however clinical trials for this therapy are immature
and need to establish efficacy before being able to reach the broader market.
Traditional healthcare is a competent method of healthcare delivery
for a variety of health conditions, however as life evolves newer conditions
will surface. Emerging cellular therapies offers the opportunity to respond
to life’s demands while also improving upon the healthcare industry within
the United States. Personalized medicine via induced pluripotent stem cells,
human embryonic stem cells, and tissue engineering possesses the ability
to enhance healthcare delivery. Regenerative rehabilitation is a potentially
life transforming area of medicine that will rapidly improve one’s quality
of life while also improving an individual’s ability to complete their daily
occupations. Regenerative medicine is the next sector of the healthcare
industry so individuals should currently have professionally administered
and controlled access to the treatment in order to expedite the FDA approval
process.
Method
Academic journals were researched through EBSCOhost and
Academic Search Complete databases for this literature review. Keywords and
phrases commonly used included: regenerative, medicine, stem cells, adult
stem cells, injuries, conditions, target population, therapy, corporatization,
regenerative medicine practice, and uses of stem cells. Additionally,
websites with government domains or websites of professionally accepted
practices were accessed for research. Information was then gathered to be
analyzed, interpreted, and synthesized for discussion within the article.
Relationship
Healthcare Industry
The history of the healthcare industry from the late 1900’s on is
known as the corporatization era, during this period large companies
controlled the healthcare scene and instituted the use of advanced technology
(Shi & Singh, 2015). Regenerative medicine is on the cusp of reaching
government approval; it could become a dynamic, vital and profitable
sector of the healthcare industry within America that relies solely on
advanced technology. Rao (2015) acknowledges that the National Institute
of Health provides the most research dollars in the United States and that the
organization is a strong supporter of regenerative medicine. As discussed
earlier, the traditional healthcare companies may not hold a place in the
commercialization of regenerative medicine because of the unique nature
of its delivery, however for those that adapt to the demands of delivery,
there will be a vast amount of revenue and profit available. Regenerative
medicine will be an exciting, challenging, polarizing, and profit driven field
Published by Encompass, 2018
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of medicine that relies on competition to enhance the quality of the product
for therapeutic use.
Occupational Science Connection
Christensen and Townsend (2010) recognize that occupational
deprivation takes place when an individual is not able to participate in their
valued occupations for a sustained period of time. Injuries and illnesses
limit one’s ability to perform daily functions as well as other life functions,
consequently these individuals will experience a decreased quality of life.
Occupations are an integral part of one’s life, and without them one’s identity
and psychosocial processes may become just as impacted as their physical
deficits. This is another powerful reason that stem cell therapy should be
considered as a viable treatment for affected individuals. Regenerative
therapy is dynamic, it extends to all parts of life for individuals and it can
help eliminate unnecessary occupational injustices that individuals will
experience throughout their lifetime.
Communication is an essential occupation of humans, and without
it there is an occupational disruption that extends into every interaction
that one will experience within a given day. Wormal, Fishman, Tolly and
Birchall (2015) explore how regenerative medicine is being implemented
in otorhinolaryngology and the potential impact that would take place from
being able to acutely treat a condition. Communication is frequently disrupted
with any condition related to otorhinolaryngology so it would be powerful
to observe successful results in regenerative treatment for one of these
conditions. Despite the complexity of the circumstances, tissue engineering,
cellular therapies and other regenerative approaches are targeting many of
the diseases in this specialty field (Wormal, Fishman, Tolly & Brichall,
2015). Reestablishing communication after injury or disease would signify
a significant and monumental moment for regenerative therapy to address
social participation as a valued occupation.
Connection as a Future Healthcare Provider
Future healthcare providers will encounter and interact with
individuals undergoing a stem cell intervention. Therapists must be able to
provide competent and comprehensive rehabilitation to these individuals
to ensure their rehabilitation is successfully completed. For example,
individuals who undergo regeneration of their third phalanx will be relearning
a skill like writing or typing that they had possessed before the amputation.
Ambrosio et al. (2010) recognize that stem cells are capable of undergoing
rehabilitation it is essential that the regenerative and rehabilitative fields
work in synchronization to ensure that they complement one another for
high quality future healthcare. Lyons et al. (2009) discussed that stem
cell rehabilitation is psychologically demanding too because individuals
undergo a gradual recovery back into their ADL’s and IADL’s. Although
https://encompass.eku.edu/kjus/vol2/iss1/6
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one may quickly regain a physical function they still must undergo
rehabilitation and learn to reuse the regenerated body part, this is as
demanding on the body as it is the mind. There is a myriad of conditions
that could benefit from regenerative rehabilitation and it is critical that
clinically relevant strategies are recognized and implemented to ensure that
individuals are delivered the highest quality of healthcare to improve their
quality of life.
Relevance
Current Healthcare Policies
Healthcare policies and cost are a multidimensional topic of
regenerative medicine that will take some experience to establish into
effective law and regulation. Creating policies for a therapy still in the
clinical trial phase is a demanding and difficult task, however there are
many policies, guidelines, and business models projected with FDA
approval. French (2016) discusses two different business models projected
for stem cell therapy. One option is for the patient to pay one sum as if
it were a surgical operation while the other entertains the idea of making
annual payments due to the therapy’s unique and time sensitive nature of
regeneration (French, 2016). Health insurance companies will be needed to
ensure that healthcare providers are reimbursed for their cellular treatments.
The most direct route of payment would be the same as treating it like an
operation, this would prevent the logistical complication of switching
health insurance plans while making payments during a patient’s stem
cell intervention. It will be an interesting debate to follow as regenerative
medicine progresses through the trial and challenges of the Food and Drug
Administration. Levine (2008) surveyed stem cell scientists about national
stem cell policies and through this survey it was verified that the United
States’ policies are currently considered as too restrictive. Consequently,
many of these individuals are moving to other countries to study with more
freedom and autonomy. Overall, policies, guidelines, and cost is currently a
fluid situation that will require some trial runs to be able and recognize what
works best for patients and healthcare providers alike.
Implications on Healthcare Delivery
Personalized medicine through regenerative stem cells is an
unparalleled treatment and cure for a countless number of diseases, defects,
disabilities, conditions, and injuries. Pluripotent stem cells are able to
differentiate into every type of human cell, therefore they have the most
potential benefits within regenerative medicine. Dr. O’ Brien and Dr. Barry
(2009) claim that enormous potential has been demonstrated in preclinical
animal studies, but that early human studies have not been quite as promising.
Delivery of this pioneering and innovative healthcare will
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possess unrivaled challenges because there has been no experience within
the field of rehabilitative regenerative therapy. In theory, every aspect of
regenerated structures would react as if they were the original structures,
yet it is unbeknownst how a regenerated structure will handle stress over
time, how it will develop strength and endurance over time, how it will age
over time, how to conduct therapy if there were complications, how it will
react to an injury and numerous other difficulties that may arise. Essentially,
regenerative structures are ideal on paper, but reality places demands that
will eventually demonstrate the strengths and weaknesses of regenerating
human structures. As a future healthcare provider, it would be extremely
interesting to work in regenerative therapy, and hopefully regenerated
tissues function as if they were original tissues. Despite the uncertainty,
any unexpected challenges that arise from regenerative medicine would be
received and addressed to the best of the ability of a therapist to enhance the
client’s quality of life
Consequence on Healthcare Delivery
Risks are inherent with all forms of healthcare delivery, and with a
groundbreaking field of regenerative therapy emerging the risks are even
more notorious and prominent. Minimal understanding of such a powerful
therapy should always be considered a risk itself and it is important that
it is fully understood before being implemented into practice. PreynantSeauve and Karl-Heinz (2011) highlight the infamous complication of
autoimmune rejection of stem cells in patients. In order to circumvent the
risk, one can try a immunosuppressant with a similar risk as any organ
transplant recipient (Preynant-Seauve & Karl-Heinz, 2011) or autograft
stem cells from themselves; however, the issue surrounding the decision
to autograft is that an individual will not be able to target genetic diseases
because their stem cells are susceptible to the same genetic makeup that
made their condition possible (French, 2016). If this complication were to
arise, it would need to be immediately addressed or there would risk of
losing the regenerated body structure, as well as, risk to the patient’s overall
health and well-being. Healthcare delivery is a dynamic intervention that
relies on knowledgeable and competent health professionals that are able to
recognize risks, complications, and progress for their clients.
Conclusion
Therapeutic intervention through stem cells is a powerful therapy
that could potentially eliminate illnesses, alleviate injuries, minimize
chronic conditions and treat a variety of other physical deficits. Bioethical
debates will continue throughout the years of regenerative medicine’s
infancy, however there is little debate that humans would minimize such a
life changing technology. Policies and the delivery of healthcare will evolve
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and adapt to meet the demands of regenerative medicine as it emerges.
Occupational injustices will exist as long as physical disabilities, injuries,
and other conditions prevent individuals from participating in their valued
occupations; however, regenerative therapy can help reintroduce an
individual to their occupations, subsequently improving their quality of life.
This unique type of therapy has implications for healthcare beyond that of
any modern therapy and it will be interesting to see what emerges in the
next few years.
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